RETRACTION: Activation of MEK1/2/Nrf-2 Signaling Pathway by Epstein-Barr Virus-Latent Membrane Protein 1 Enhances Autophagy and Cisplatin Resistance in T-Cell Lymphoma.

Pathology AC

Open source

DOI
10.1155/ancp/9846503
Published
2025
Container
Analytical cellular pathology (Amsterdam)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/ancp/9846503,
  title = {RETRACTION: Activation of MEK1/2/Nrf-2 Signaling Pathway by Epstein-Barr Virus-Latent Membrane Protein 1 Enhances Autophagy and Cisplatin Resistance in T-Cell Lymphoma.},
  author = {Pathology AC},
  year = {2025},
  journal = {Analytical cellular pathology (Amsterdam)},
  doi = {10.1155/ancp/9846503},
  url = {https://doi.org/10.1155/ancp/9846503}
}

RIS

TY  - JOUR
TI  - RETRACTION: Activation of MEK1/2/Nrf-2 Signaling Pathway by Epstein-Barr Virus-Latent Membrane Protein 1 Enhances Autophagy and Cisplatin Resistance in T-Cell Lymphoma.
AU  - Pathology AC
PY  - 2025
JO  - Analytical cellular pathology (Amsterdam)
DO  - 10.1155/ancp/9846503
UR  - https://doi.org/10.1155/ancp/9846503
ER  - 

APA

AC, P. (2025). RETRACTION: Activation of MEK1/2/Nrf-2 Signaling Pathway by Epstein-Barr Virus-Latent Membrane Protein 1 Enhances Autophagy and Cisplatin Resistance in T-Cell Lymphoma.. Analytical cellular pathology (Amsterdam). https://doi.org/10.1155/ancp/9846503

Source records